Skip to main content

Table 4 Multivariable-adjusted mean changes in cardiovascular disease risk factors (95% CI) over 6ā€‰years of follow-up among individuals without CVD or diabetes (includes normoglycemic adults and adults with prediabetes), according to quartiles of sedentary time and meeting guidelines for moderate-to-vigorous physical activity (Nā€‰~ā€‰6114)

From: Are sedentary behavior and physical activity independently associated with cardiometabolic benefits? The Hispanic Community Health Study/Study of Latinos

Change in CVD risk factors

Sedentary time

P-trend

MVPA guidelinesa

P

Quartile 1

(0.8ā€“10.8ā€‰h)

Quartile 2

(10.8ā€“11.9ā€‰h)

Quartile 3

(11.9ā€“12.8ā€‰h)

Quartile 4

(12.8ā€“16.0ā€‰h)

Not meet

Meet

BMI, kg/m2

ā€ƒModel 1

0.90 (0.68, 1.13)

1.06 (0.84, 1.28)

0.83 (0.61, 1.06)

0.93 (0.74, 1.12)

0.86

0.89 (0.75, 1.03)

0.98 (0.81, 1.16)

0.35

ā€ƒModel 2

0.88 (0.65, 1.11)

1.04 (0.82, 1.26)

0.84 (0.62, 1.06)

0.93 (0.74, 1.13)

0.96

0.85 (0.71, 0.99)

1.01 (0.83, 1.18)

0.14

ā€ƒModel 3

0.83 (0.58, 1.07)

1.04 (0.82, 1.26)

0.85 (0.64, 1.07)

0.98 (0.78, 1.18)

0.56

0.83 (0.68, 0.98)

1.03 (0.86, 1.20)

0.09

Waist circumference, cm

ā€ƒModel 1

2.55 (1.97, 3.14)

2.70 (2.01, 3.38)

2.46 (1.75, 3.18)

3.23 (2.65, 3.81)

0.22

2.49 (2.05, 2.93)

3.02 (2.55, 3.49)

0.08

ā€ƒModel 2

2.69 (2.06, 3.31)

2.76 (2.08, 3.44)

2.53 (1.86, 3.20)

2.86 (2.27, 3.45)

0.84

2.66 (2.21, 3.11)

2.77 (2.31, 3.24)

0.70

ā€ƒModel 3

2.64 (1.96, 3.31)

2.76 (2.08, 3.44)

2.54 (1.87, 3.22)

2.90 (2.29, 3.51)

0.72

2.62 (2.15, 3.08)

2.81 (2.34, 3.29)

0.55

Systolic BP, mmHg

ā€ƒModel 1

0.69 (āˆ’0.15, 1.52)

0.97 (0.04, 1.90)

0.46 (āˆ’ā€‰0.44, 1.36)

0.56 (āˆ’ā€‰0.28, 1.41)

0.69

0.70 (0.06, 1.35)

0.63 (āˆ’ā€‰0.09, 1.34)

0.88

ā€ƒModel 2

0.70 (āˆ’0.20, 1.61)

0.99 (0.09, 1.88)

0.62 (āˆ’ā€‰0.28, 1.52)

0.42 (āˆ’ā€‰0.44, 1.28)

0.61

0.77 (0.10, 1.43)

0.58 (āˆ’ā€‰0.14, 1.30)

0.71

ā€ƒModel 3

0.87 (āˆ’0.10, 1.83)

0.99 (0.10, 1.89)

0.58 (āˆ’0.33, 1.48)

0.30 (āˆ’ā€‰0.56, 1.17)

0.36

0.78 (0.09, 1.47)

0.56 (āˆ’ā€‰0.20, 1.32)

0.69

Diastolic BP, mmHg

ā€ƒModel 1

0.14 (āˆ’0.57, 0.85)

0.58 (āˆ’0.08, 1.25)

0.19 (āˆ’ā€‰0.54, 0.92)

0.83 (0.11, 1.54)

0.27

0.24 (āˆ’ā€‰0.28, 0.76)

0.66 (0.10, 1.21)

0.27

ā€ƒModel 2

0.30 (āˆ’0.44, 1.04)

0.70 (0.04, 1.37)

0.26 (āˆ’0.45, 0.97)

0.42 (āˆ’ā€‰0.27, 1.11)

0.96

0.43 (āˆ’ā€‰0.10, 0.95)

0.41 (āˆ’ā€‰0.16, 0.98)

0.97

ā€ƒModel 3

0.44 (āˆ’0.37, 1.24)

0.72 (0.05, 1.38)

0.21 (āˆ’ā€‰0.50, 0.93)

0.32 (āˆ’ā€‰0.38, 1.02)

0.67

0.44 (āˆ’ā€‰0.12, 0.99)

0.40 (āˆ’ā€‰0.21, 1.01)

0.93

LDL-cholesterol, mg/dl

ā€ƒModel 1

āˆ’4.13 (āˆ’5.90, āˆ’2.35)

āˆ’2.58 (āˆ’5.00, āˆ’ā€‰0.17)

āˆ’3.45 (āˆ’ā€‰5.53, āˆ’1.37)

āˆ’3.24 (āˆ’ā€‰5.18, āˆ’1.31)

0.61

āˆ’2.95 (āˆ’ā€‰4.38, āˆ’ā€‰1.52)

āˆ’3.80 (āˆ’ā€‰5.35, āˆ’ā€‰2.24)

0.40

ā€ƒModel 2

āˆ’4.52 (āˆ’6.40, āˆ’ā€‰2.65)

āˆ’ā€‰2.64 (āˆ’ā€‰5.04, āˆ’ā€‰0.23)

āˆ’ā€‰3.07 (āˆ’ā€‰5.11, āˆ’ā€‰1.03)

āˆ’3.32 (āˆ’ā€‰5.10, āˆ’ā€‰1.55)

0.41

āˆ’ā€‰2.66 (āˆ’ā€‰4.08, āˆ’ā€‰1.25)

āˆ’ā€‰4.19 (āˆ’ā€‰5.75, āˆ’ā€‰2.63)

0.13

ā€ƒModel 3

āˆ’4.71 (āˆ’ā€‰6.73, āˆ’ā€‰2.69)

āˆ’2.68 (āˆ’ā€‰5.10, āˆ’ā€‰0.25)

āˆ’2.96 (āˆ’ā€‰5.02, āˆ’ā€‰0.90)

āˆ’ā€‰3.21 (āˆ’ā€‰5.04, āˆ’ā€‰1.38)

0.35

āˆ’2.96 (āˆ’ā€‰4.44, āˆ’ā€‰1.48)

āˆ’3.87 (āˆ’ā€‰5.50, āˆ’ā€‰2.24)

0.41

HDL-cholesterol, mg/dl

ā€ƒModel 1

1.22 (0.46, 1.98)

1.19 (0.48, 1.89)

2.11 (1.23, 3.00)

1.60 (0.91, 2.29)

0.26

1.68 (1.17, 2.19)

1.37 (0.82, 1.93)

0.43

ā€ƒModel 2

1.66 (0.85, 2.48)

1.22 (0.57, 1.88)

1.94 (1.10, 2.77)

1.28 (0.56, 1.99)

0.75

1.74 (1.21, 2.26)

1.29 (0.73, 1.85)

0.27

ā€ƒModel 3

1.86 (0.95, 2.77)

1.23 (0.57, 1.88)

1.91 (1.06, 2.76)

1.11 (0.36, 1.86)

0.43

1.71 (1.15, 2.27)

1.32 (0.71, 1.93)

0.39

Triglycerides, mg/dlb

ā€ƒModel 1

0.97 (0.93, 1.01)

0.95 (0.91, 0.99)

0.95 (0.91, 0.98)

0.97 (0.94, 1.00)

0.88

0.96 (0.93, 0.98)

0.96 (0.93, 0.99)

0.93

ā€ƒModel 2

0.95 (0.91, 0.99)

0.95 (0.91, 0.99)

0.95 (0.92, 0.99)

0.97 (0.94, 1.00)

0.51

0.95 (0.93, 0.98)

0.96 (0.93, 0.99)

0.62

ā€ƒModel 3

0.94 (0.90, 0.99)

0.95 (0.91, 0.98)

0.96 (0.92, 0.99)

0.98 (0.95, 1.01)

0.27

0.95 (0.93, 0.98)

0.96 (0.93, 0.99)

0.59

Fasting glucose, mg/dl

ā€ƒModel 1

3.46 (2.73, 4.19)

4.45 (3.52, 5.39)

3.53 (2.78, 4.27)

3.87 (3.11, 4.63)

0.71

4.60 (4.04, 5.17)

2.96 (2.36, 3.56)

<ā€‰0.0001

ā€ƒModel 2

2.92 (2.15, 3.69)

4.37 (3.45, 5.29)

3.69 (2.94, 4.44)

4.25 (3.48, 5.02)

0.04

4.23 (3.67, 4.80)

3.34 (2.75, 3.93)

0.01

ā€ƒModel 3

2.92 (2.10, 3.74)

4.38 (3.46, 5.31)

3.63 (2.88, 4.39)

4.29 (3.49, 5.10)

0.07

4.32 (3.73, 4.91)

3.25 (2.61, 3.89)

0.01

2-h glucose, mg/dl

ā€ƒModel 1

7.75 (5.17, 10.32)

9.70 (6.93, 12.48)

8.11 (4.88, 11.34)

9.48 (7.14, 11.82)

0.44

8.55 (6.74, 10.36)

8.99 (6.88, 11.10)

0.73

ā€ƒModel 2

6.92 (4.37, 9.47)

9.93 (7.08, 12.78)

8.48 (5.34, 11.61)

9.75 (7.40, 12.11)

0.14

8.78 (7.00, 10.55)

8.77 (6.70, 10.84)

0.99

ā€ƒModel 3

7.36 (4.73, 9.98)

10.04 (7.19, 12.89)

8.25 (5.07, 11.43)

9.45 (6.90, 12.00)

0.39

8.63 (6.78, 10.48)

8.93 (6.81, 11.05)

0.82

HbA1c, mg/dl

ā€ƒModel 1

0.15 (0.13, 0.18)

0.18 (0.16, 0.21)

0.15 (0.13, 0.17)

0.17 (0.15, 0.19)

0.63

0.16 (0.14, 0.17)

0.17 (0.15, 0.19)

0.25

ā€ƒModel 2

0.15 (0.13, 0.17)

0.18 (0.16, 0.21)

0.16 (0.14, 0.18)

0.17 (0.15, 0.19)

0.21

0.16 (0.14, 0.17)

0.17 (0.15, 0.19)

0.18

ā€ƒModel 3

0.14 (0.12, 0.16)

0.18 (0.16, 0.21)

0.16 (0.14, 0.18)

0.17 (0.15, 0.20)

0.11

0.16 (0.14, 0.17)

0.17 (0.15, 0.19)

0.33

Fasting insulin, mU/Lb

ā€ƒModel 1

1.23 (1.17, 1.29)

1.28 (1.21, 1.35)

1.23 (1.17, 1.29)

1.24 (1.18, 1.29)

0.99

1.27 (1.23, 1.31)

1.21 (1.17, 1.26)

0.03

ā€ƒModel 2

1.19 (1.14, 1.25)

1.26 (1.20, 1.33)

1.24 (1.18, 1.30)

1.27 (1.22, 1.33)

0.05

1.26 (1.22, 1.30)

1.22 (1.18, 1.27)

0.16

ā€ƒModel 3

1.20 (1.14, 1.27)

1.27 (1.20, 1.34)

1.23 (1.18, 1.30)

1.26 (1.21, 1.31)

0.28

1.26 (1.22, 1.31)

1.22 (1.17, 1.27)

0.10

HOMA-IRb

ā€ƒModel 1

1.28 (1.22, 1.35)

1.33 (1.25, 1.41)

1.27 (1.21, 1.34)

1.29 (1.23, 1.35)

0.85

1.33 (1.28, 1.37)

1.25 (1.20, 1.31)

0.01

ā€ƒModel 2

1.23 (1.17, 1.30)

1.31 (1.24, 1.39)

1.29 (1.22, 1.36)

1.33 (1.27, 1.39)

0.04

1.31 (1.27, 1.36)

1.27 (1.22, 1.32)

0.11

ā€ƒModel 3

1.25 (1.18, 1.32)

1.32 (1.24, 1.40)

1.28 (1.22, 1.35)

1.32 (1.26, 1.38)

0.21

1.32 (1.27, 1.37)

1.26 (1.21, 1.32)

0.06

  1. Excluded 1935 adults with diabetes (nā€‰=ā€‰1629) or CVD (nā€‰=ā€‰509). Note 203 adults had both diabetes and CVD
  2. Model 2 further adjusted for baseline household income, education, employment status, Hispanic/Latino background, field center, and nativity status, smoking, alcohol consumption, health insurance status, healthcare utilization, self-reported health, diet quality, change in health insurance, baseline BMI and waist-hip ratio (except in modeling change of BMI and waist circumference)
  3. Model 3 adjusted for Model 2 covariates and sedentary time in models of MVPA or MVPA in models of sedentary time
  4. aMeeting 2018 physical activity guidelines defined using measured activity scaled to 7 days of accelerometer wear as 150 minutes/week moderate intensityphysical activity, 75 minutes/week vigorous intensity activity, or an equivalent combination of both
  5. bGeometric means (95% CI) presented for triglycerides, fasting insulin, HOMA-IR